BMO Capital initiates coverage on Henry Schein with $85 price target
BMO Capital initiates coverage on Henry Schein with a Market Perform rating and a price target of $85.

*this image is generated using AI for illustrative purposes only.
BMO Capital has initiated coverage on Henry Schein with a Market Perform rating and a price target of $85. The rating reflects a neutral outlook on the stock's performance potential.
Coverage Details
The research note provides an initial assessment of Henry Schein's market position. The price target of $85 serves as a benchmark for the stock's valuation.
| Metric | Value |
|---|---|
| Rating | Market Perform |
| Price Target | $85 |
What specific market factors could drive Henry Schein's stock above the $85 price target?
How might recent changes in the healthcare supply chain impact Henry Schein's future performance?
What are the potential risks that could lead BMO Capital to revise its Market Perform rating?

























